INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

DVAXDYNAVAX TECHNOLOGIES CORP

CIK 0001029142

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score9
Connections3with evidence

DVAX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MA
Metzinger Joseph AnthonyVP, Chief Accounting Officer
DVAXDYNAVAX TECHNOLOGIES CORP
Tender of shares
U—
7,129 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Metzinger Joseph AnthonyVP, Chief Accounting Officer · Feb 10, 2026
  • ← Insider ofevidence
    Emini EmilioDirector · Feb 10, 2026
9
MA
Metzinger Joseph AnthonyVP, Chief Accounting Officer
DVAXDYNAVAX TECHNOLOGIES CORP
Disposition to issuer
D
—
31.5K sh
Feb 10, 2026
Feb 10, 2026
traded Feb 10, 2026
+0d
SEC FORM 4

Evidence

9
MA
Metzinger Joseph AnthonyVP, Chief Accounting Officer
DVAXDYNAVAX TECHNOLOGIES CORP
Disposition to issuer
D—
25.5K sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC FORM 4

Evidence

9
EE
Emini EmilioDirector
DVAXDYNAVAX TECHNOLOGIES CORP
Disposition to issuer
D—
10.1K sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC FORM 4

Evidence

9
EE
Emini EmilioDirector
DVAXDYNAVAX TECHNOLOGIES CORP
Disposition to issuer
D—
42.8K sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC FORM 4

Evidence

9
EE
Emini EmilioDirector
DVAXDYNAVAX TECHNOLOGIES CORP
Disposition to issuer
D—
7,125 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC FORM 4

Evidence

Source error

Price history for DVAX is unavailable.

An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.